Lumida
/FTLF
⌘K
FitLife Brands Inc

FitLife Brands Inc

FTLF
$11.06USD-0.90%-0.10 today

MARKET CAP

103.9M

P/E (TTM)

17.4x

FWD P/E

11.0x

DAY RANGE

$11 – $11

52W RANGE

$9
$21

AI Summary

Stalk
Buy NowMedium

FTLF is in an early Stage 1 consolidation after a prior decline; a Momentum Breakout candle pushed price above the base with rising volume. Medium-term bias is bullish, supported by repaired EMAs and active breakout structure. Short-term timing favors immediate engagement as price holds above rising 9/21 EMAs on a shallow retest. Execution should target pullbacks into the breakout zone near those EMAs. Primary risks include failure to hold the breakout level and overhead resistance near the flattening 200 DMA.

  • Q1 revenue reached $25.3M (+59% YoY), led by 166% wholesale jump to $14.1M
  • Online revenue rose 6% YoY to $11.2M, with $0.8M on Amazon in March
  • Legacy segment revenue declined 22% YoY, highlighting core weakness
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

FitLife Brands, Inc. (NASDAQ:FTLF) operates in the health and wellness sector, specializing in nutritional supplements across various brands. Following its recent acquisition of Erwin Naturals, the company is working to enhance its product portfolio and distribution capabilities. FitLife navigates a competitive landscape marked by challenges with legacy products while capitalizing on e-commerce opportunities, particularly through Amazon, as health trends gain traction among consumers looking for fitness-related products.

Bull says

  • Q1 revenue reached $25.3M (+59% YoY), led by 166% wholesale jump to $14.1M
  • Online revenue rose 6% YoY to $11.2M, with $0.8M on Amazon in March
  • Three-year shelf-life plan aimed at cutting obsolescence and lifting margins
  • Favorable e-commerce trend and positive interest-rate sensitivity support growth
  • High growth factor and quality score indicate long-term expansion resilience

Bear says

  • Legacy segment revenue declined 22% YoY, highlighting core weakness
  • Gross margin compressed to 37.6% from 43.1% due to low-margin Erwin mix
  • Out-of-stock issues cost “hundreds of thousands” in lost Amazon sales
  • Net income fell to $1.7M, weighed by higher amortization and interest
  • Negative earnings yield and poor profitability signal valuation and liquidity risks
  • Analyst sentiment turned bearish with multiple price-target cuts

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-20-2026neutral

Transcript signals

Bull points

  • For the first quarter of 2026, total revenue was 25.3 million, an increase of 59% compared to the same quarter last year. With the increase driven primarily by the acquisition of Erwin, partially offset by weakness in legacy fit life.
  • We expect Erwin's margins to continue to increase over time as we work through a number of supply chain and other initiatives.
  • we are encouraged that monthly revenue increased sequentially throughout the quarter.

Bear points

  • Net income for the first quarter of 2026 was $1.7 million, compared to 2.0 million during the first quarter of 2025, with the decline driven primarily by higher amortization expense and interest expense associated with the acquisition of Erwin.
  • Adjusting for the loss of Costco US and Rite Aid as customers prior to our acquisition of Erwin, and removing CBD for both periods due to the company's decision to exit the CBD market, organic revenue for Erwin during the first quarter of 2026 declined approximately 13% year over year. We estimate that approximately 1 to 1.5 million, or more than half of the decline, is due to lost revenue from the out-of-stock situations discussed on our previous earnings call.
  • Gross margin was 37.6%, compared to 43.1% during the first quarter of 2025, with the decline primarily due to the acquisition of Erwin, which has historically operated at a lower gross margin than Legacy FitLife.
Read full transcript analysis ›